Summit Therapeutics Inc (SMMT)
8.685
-2.24
(-20.47%)
USD |
NASDAQ |
May 31, 16:00
8.70
+0.02
(+0.17%)
After-Hours: 20:00
Summit Therapeutics Cash from Operations (Quarterly): -30.13M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -30.13M |
| December 31, 2023 | -19.46M |
| September 30, 2023 | -14.90M |
| June 30, 2023 | -29.27M |
| March 31, 2023 | -13.13M |
| December 31, 2022 | 5.191M |
| September 30, 2022 | -8.555M |
| June 30, 2022 | -19.22M |
| March 31, 2022 | -19.00M |
| December 31, 2021 | -9.179M |
| September 30, 2021 | -23.56M |
| June 30, 2021 | -19.17M |
| March 31, 2021 | -20.67M |
| December 31, 2020 | -7.971M |
| September 30, 2020 | -16.65M |
| June 30, 2020 | -18.53M |
| March 31, 2020 | -4.959M |
| October 31, 2019 | -8.613M |
| July 31, 2019 | -10.23M |
| April 30, 2019 | 1.804M |
| Date | Value |
|---|---|
| January 31, 2019 | -6.976M |
| October 31, 2018 | -4.696M |
| July 31, 2018 | -13.86M |
| April 30, 2018 | -9.578M |
| January 31, 2018 | -8.828M |
| October 31, 2017 | -13.79M |
| July 31, 2017 | 12.32M |
| April 30, 2017 | -10.28M |
| January 31, 2017 | -6.718M |
| October 31, 2016 | 34.41M |
| July 31, 2016 | -3.208M |
| April 30, 2016 | -9.306M |
| January 31, 2016 | -7.227M |
| October 31, 2015 | -6.388M |
| July 31, 2015 | -4.896M |
| April 30, 2015 | -5.96M |
| January 31, 2015 | -4.464M |
| October 31, 2014 | -3.164M |
| July 31, 2014 | -6.543M |
| April 30, 2014 | -2.416M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-30.13M
Minimum
Mar 2024
5.191M
Maximum
Dec 2022
-15.16M
Average
-16.65M
Median
Sep 2020
Cash from Operations (Quarterly) Benchmarks
| Merck & Co Inc | 3.09B |
| Novo Integrated Sciences Inc | -1.714M |
| Insmed Inc | -184.04M |
| Retractable Technologies Inc | -2.022M |
| BioCardia Inc | -1.53M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 19.87M |
| Cash from Financing (Quarterly) | 0.485M |
| Free Cash Flow | -93.84M |
| Free Cash Flow Per Share (Quarterly) | -0.0429 |
| Free Cash Flow Yield | -1.54% |